Shaanxi Kanghui Pharmaceutical Co., Ltd.SSE: 603139

Notice on Convening the 3rd Extraordinary General Meeting in 2026

· Issued by Shaanxi Kanghui Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 6 pages · Chinese

Summary by 6ix AI

Key agenda items include proposals related to investments and an employee stock incentive plan. The notice outlines the voting procedures and registration requirements for shareholders wishing to attend the meeting.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Notice on Convening the 3rd Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shaanxi Kanghui Pharmaceutical Co., Ltd. on 6ix

Earlier from Shaanxi Kanghui Pharmaceutical

Later from Shaanxi Kanghui Pharmaceutical

All Shaanxi Kanghui Pharmaceutical news releases